StockWatch
·
Pharmaceuticals
Quarterly Result4 Nov 2026, 07:32 am

Lupin Ltd Declares Unaudited Q2 FY27 Results

AI Summary

Lupin Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results on November 3, 2026. The company also reported the exercise of stock options, leading to the allotment of 57,436 equity shares. A final dividend of ₹18 per equity share was disbursed on August 6, 2026. The company provided for diminution in the value of investment in a subsidiary amounting to ₹769.3 million and also settled an antitrust matter for ₹3,162.8 million.

Key Highlights

  • Lupin Ltd declared unaudited standalone and consolidated financial results.
  • Results are for the quarter and half-year ended September 30, 2026.
  • 57,436 equity shares allotted upon exercise of stock options.
  • Final dividend of ₹18 per share disbursed.
  • Provision made for diminution in investment value.